Dr. Waugh's Lab Logo MCL Home David S. Waugh National Cancer Institute Home Page Dr. Waugh's Home Page Dr. Waugh's Research Summary Dr. Waugh's Publications Dr. Waugh's Staff Dr. Waugh's Structure Gallery Dr. Waugh's Technical Information
 
pRK603
 
 Description: This TEV protease expression vector is intended to be used for controlled intracellular processing of fusion proteins (TEV protease substrates) in E. coli.
   
 Origin: A pZ derivative (Lutz and Bujard, 1997)
   
 Replicon: p15A
   
 Antibotic Resistance: Kanamycin
   
 Promotor: Synthetic λPL/tetO
   
 Inducer: anhydrotetracycline (100 µg/liter)
   
 Notes: Expression of the TEV protease gene on pRK603 will be constitutive unless the host strain produces Tet repressor. Regulated expression can be achieved in DH5alphaPro™ or BL21Pro™ cells (Clontech). For best results, perform intracellular processing experiments at 30 °C.
   
 Literature Citations: Kapust, R. B. and Waugh, D. S. (2000). Controlled intracellular processing of fusion proteins by TEV protease. Prot. Expr. Purif. 19: 312-318. Lutz, R. and Bujard, H. (1997). Independent and tight regulation of transcriptional units in Escherichia coli via the LacR/O, the TetR/O and AraC/I1-I2 regulatory elements. Nucl. Acids Res. 25: 1203-10.
   
 Nucleotide Sequence:  
   
   
MCL Bottom Navigation Bar MCL Home MCL Web Site Map MCL Contact Information MCL Web Disclaimer NCI-FCRDC Web Site NCI-CCR Web Site